Table 1

Characteristics of the included studies

First author, yearMean ageGender (F/M)N (K/P)Doses of ketamineTimeType of injectionStart time of injectionType of arthroplasty
Wong, 199624 63.78/86/1010 mg12, 24, 48, 72 hoursEpiduralImmediately after surgeryTKA, THA
Adam, 200513 68.527/1320/203 µg/kg/min until the patient emerged from anaesthesia, and then 1.5 µg/kg/min maintained for 48 hours0, 1, 4, 12, 24, 48 hours, before and after rehabilitative therapy on days 1 and 2IntravenousAfter the induction of anaesthesiaTKA
Aveline, 200912 7130/1925/240.2 mg/kg followed by a continuous infusion at 120 µg/kg/hour until the end of surgery, and then 60 µg/kg/hour until the second postoperative dayPACU, 2, 6, 12, 24, 48 hoursIntravenousAfter anaesthetic induction and tracheal intubationTKA
Perrin, 200925 62.55/75/70.5 mg/kg bolus followed by 4 µg/kg/min infusionPreoperative, 4, 12, 26 weeksIntravenousBefore surgical incisionTKA
Remerand, 200914 64.576/7879/750.5 mg/kg bolus followed by 2 µg/kg/min infusionPACU, 24, 48, 96, 168 hoursIntravenousBefore skin closureTHA
Guará Sobrinb, 201217 66.830/919/200.25 mg/kg2, 6, 12, 24 hoursIntra-articularBefore skin closureTKA
Cengiz, 201411 58.544/1630/306 µg/kg/min1, 3, 6, 12, 24 hoursIntravenousImmediately after orotracheal intubation continuing until wound closureTKA
Martinez, 201416 62.136/3634/380.5 mg/kg bolus followed by 3 µg/kg/min infusionPACU, 24, 48 hoursIntravenousAt the time of anaesthesia induction immediatelyTHA
Zhang, 201818 54.931/1321/232 mg/kg0, 2, 4, 8, 12, 24, 48 hoursIntra-articularAt the end of the surgeryTKA
Tan, 201915 67.953/3848/436 µg/kg/minPreoperative, 0, 24, 48, 72, 96, 120, 144, 168, 336 hoursIntravenousOnce patient was situated on the tableTKA
  • F, female;K, ketamine; M, male; N, number of patients per group; P, placebo; PACU, post-anaesthesia care unit; THA, total hip arthroplasty; TKA, total knee arthroplasty.